Dec 9 (Reuters) - CVS Health (CVS) on Tuesday forecast 2026 profit above Wall Street estimates and this year's projected earnings, signalling steady progress in the health conglomerate's turnaround plan.
CVS stock rose 5% in early trading on Tuesday.
The company in October projected double-digit earnings growth for 2026 after raising its 2025 profit forecast for the third time.
"We are closing out 2025 with meaningful momentum across our businesses and we expect another year of strong earnings growth in 2026," said Chief Financial Officer Brian Newman on Tuesday.
The company forecast 2026 adjusted profit to be in the range of $7.00 to $7.20 per share, compared with analysts' average estimate of $7.16, according to data compiled by LSEG.
It, however, expects total revenue of at least $400 billion next year, below analysts' average estimate of $419.26 billion.
CVS also raised its 2025 adjusted profit forecast to $6.60 to $6.70 per share from $6.55 to $6.65 previously.
(Reporting by Sneha S K in Bengaluru; Editing by Shinjini Ganguli)
latest_posts
- 1
Mom finds out she has cancer after noticing something was off while breastfeeding - 2Jennifer Lawrence and Josh Hutcherson to reprise their roles for new 'Hunger Games' movie 'Sunrise on the Reaping'
- 3Which Shrewd Home Gadget Can't You Reside Without?
- 4Knesset FADC extends emergency draft for 280,000 IDF reservists until January 1
- 5Vote In favor of Your Favored Sort Of Dress
- Opening Achievement: 8 Methodologies for Compelling Using time productively
- Might it be said that you are As yet Utilizing Old Tires? at These 6 Tire Brands
- Israel approves 19 new West Bank settlements in major annexation push
- See tonight’s solar storm unfold across the world
- Vote in favor of your #1 Sort of Convenience for a Family
- Misjudged Objections For Solo Voyagers
- 6 Useful Home Espresso Machines
- How one man's concern saved his brothers from heart disease
- Did we start the fire? A 400,000-year-old hearth sparks new questions about human evolution
